In vivo optical imaging of CD13/APN-expression in tumor xenografts

Journal of Biomedical Optics

Volumn 13, Issue 1, 2008, Pages

  Von Wallbrunn, Angelika ^a,b   Waldeck, Jens ^a,b   Höltke, Carsten ^a   Zühlsdorf, Michael ^a   Mesters, Rolf ^a   Heindel, Walter ^a   Schäfers, Michael ^a   Bremer, Christoph ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b FG3 and ZPG 4b   (Germany)

Author keywords

CD13 APN; fluorescence mediated tomography; fluorescence reflectance imaging; NGR Cy 5.5; optical imaging

Indexed keywords

ANGIOGENESIS; BINDING AFFINITIES; CD13/APN; CYANINE DYES; FLUORESCENCE REFLECTANCE IMAGING; FLUOROCHROME DISTRIBUTION; FLUOROCHROMES; HT-1080; HT-1080 CELLS; IN-VITRO; IN-VIVO; MCF-7 CELLS; NGR-CY 5.5; OPTICAL IMAGING; OPTICAL IMAGING METHOD; TARGET TISSUES; TISSUE SECTIONS; TOMOGRAPHIC; TUMOR ANGIOGENESIS; TUMOR TISSUES; TUMOR XENOGRAFTS;

BINDING ENERGY; BIOLOGICAL MATERIALS; FLUORESCENCE; OPTICAL IMAGE STORAGE; PEPTIDES; REFLECTION; THREE DIMENSIONAL; TOMOGRAPHY;

TUMORS;

MICROSOMAL AMINOPEPTIDASE; TUMOR MARKER; TUMOR PROTEIN;

ADENOCARCINOMA; ANIMAL; ARTICLE; EVALUATION; FEMALE; FIBROSARCOMA; FLUORESCENCE MICROSCOPY; GENE EXPRESSION PROFILING; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; OPTICAL TOMOGRAPHY; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD13; CELL LINE, TUMOR; FEMALE; FIBROSARCOMA; GENE EXPRESSION PROFILING; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NEOPLASM PROTEINS; TOMOGRAPHY, OPTICAL; TUMOR MARKERS, BIOLOGICAL;

EID: 44849126076     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.2839046     Document Type: Article

References (38)

1. C., Bremer, V., Ntziachristos, and R., Weissleder, " Optical-based molecular imaging: contrast agents and potential medical applications, ", Eur. Radiol., 13 (2), 231-243 (2003). 8ag ZZZZZZ 0938-7994 (Pubitemid 36798598)
2. J., Grimm, D. G., Kirsch, S. D., Windsor, C. F., Kim, P. M., Santiago, V., Ntziachristos, T., Jacks, and R., Weissleder, " Use of gene expression profiling to direct, in vivo, molecular imaging of lung cancer, ", Proc. Natl. Acad. Sci. U.S.A., 102 (40), 14404-14409 (2005). pna PNASA6 0027-8424 10.1073/pnas.0503920102 (Pubitemid 41429710)
3. U., Mahmood and R., Weissleder, " Near-infrared optical imaging of proteases in cancer, ", Mol. Cancer Ther., 2 (5), 489-496 (2003).
4. V., Ntziachristos, C., Bremer, and R., Weissleder, " Fluorescence imaging with near-infrared light: new technological advances that enable, in vivo, molecular imaging, ", Eur. Radiol., 13 (1), 195-208 (2003). 8ag ZZZZZZ 0938-7994 (Pubitemid 36790510)
5. E. E., Graves, D., Yessayan, G., Turner, R., Weissleder, and V., Ntziachristos, " Validation of, in vivo, fluorochrome concentrations measured using fluorescence molecular tomography, ", J. Biomed. Opt., 10 (4), 44019 (2005). jbo JBOPFO 1083-3668
6. X., Montet, V., Ntziachristos, J., Grimm, and R., Weissleder, " Tomographic fluorescence mapping of tumor targets, ", Cancer Res., 65 (14), 6330-6336 (2005). cnr CNREA8 0008-5472 10.1158/0008-5472.CAN-05-0382 (Pubitemid 40994419)
7. V., Ntziachristos, C., Bremer, E. E., Graves, J., Ripoll, and R., Weissleder, " In vivo, tomographic imaging of near-infrared fluorescent probes, ", Mol. Imaging, 1 (2), 82-88 (2002). bwf MIOMBP 1535-3508 10.1162/153535002320162732
8. V., Ntziachristos, C., Bremer, C., Tung, and R., Weissleder, " Imaging cathepsin B up-regulation in HT-1080 tumor models using fluorescence-mediated molecular tomography (FMT), ", Acad. Radiol., 9, Suppl 2, S323-325 (2002). 8af ZZZZZZ 1076-6332
9. V., Ntziachristos, C. H., Tung, C., Bremer, and R., Weissleder, " Fluorescence molecular tomography resolves protease activity, in vivo, ", Nat. Med., 8 (7), 757-760 (2002). 84o ZZZZZZ 1078-8956 (Pubitemid 34778731)
10. D., Riemann, A., Kehlen, and J., Langner, " CD13 - not just a marker in leukemia typing, ", Immunol. Today, 20 (2), 83-88 (1999). imt IMTOD8 0167-4919 10.1016/S0167-5699(98)01398-X (Pubitemid 29136633)
11. S. V., Bhagwat, J., Lahdenranta, R., Giordano, W., Arap, R., Pasqualini, and L. H., Shapiro, " CD13/APN is activated by angiogenic signals and is essential for capillary tube formation, ", Blood, 97 (3), 652-659 (2001). blo BLOOAW 0006-4971 10.1182/blood.V97.3.652 (Pubitemid 32113397)
12. R., Pasqualini, E., Koivunen, R., Kain, J., Lahdenranta, M., Sakamoto, A., Stryhn, R. A., Ashmun, L. H., Shapiro, W., Arap, and E., Ruoslahti, " Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis, ", Cancer Res., 60 (3), 722-727 (2000). cnr CNREA8 0008-5472 (Pubitemid 30094573)
13. Y., Sato, " Role of aminopeptidase in angiogenesis, ", Biol. Pharm. Bull., 27 (6), 772-776 (2004). 3pa BPBLEO 0918-6158 10.1248/bpb.27.772 (Pubitemid 41701786)
14. W., Arap, R., Pasqualini, and E., Ruoslahti, " Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model, ", Science, 279 (5349), 377-380 (1998). sci SCIEAS 0036-8075 10.1126/science.279.5349.377 (Pubitemid 28063372)
15. G., Colombo, F., Curnis, G. M., De Mori, A., Gasparri, C., Longoni, A., Sacchi, R., Longhi, and A., Corti, " Structure-activity relationships of linear and cyclic peptides containing the, NGR, tumor-homing motif, ", J. Biol. Chem., 277 (49), 47891-47897 (2002). jbc JBCHA3 0021-9258 10.1074/jbc.M207500200 (Pubitemid 36159317)
16. Y., van Hensbergen, H. J., Broxterman, Y. W., Elderkamp, J., Lankelma, J. C., Beers, M., Heijn, E., Boven, K., Hoekman, and H. M., Pinedo, " A doxorubicin-C NGR C-peptide conjugate with prodrug properties, ", Biochem. Pharmacol., 63 (5), 897-908 (2002). bcq BCPCA6 0006-2952 (Pubitemid 34243003)
17. Z., Zhang, H., Harada, K., Tanabe, H., Hatta, M., Hiraoka, and S. I., Nishimoto, " Aminopeptidase N/CD13 targeting fluorescent probes: synthesis and application to tumor cell imaging, ", Peptides, 26 (11), 2182-2187 (2005). 6lh ZZZZZZ 0196-9781 (Pubitemid 41584082)
18. ′ -deoxyuridine prodrugs conjugated with a tumor-homing cyclic peptide C NGR C by ester linkers: synthesis, reactivity, and tumor-cell-selective cytotoxicity, ", Pharm. Res., 22 (3), 381-389 (2005). phv PHREEB 0724-8741 10.1007/s11095-004-1875-x (Pubitemid 40558496)
19. F., Pastorino, C., Brignole, D., Marimpietri, M., Cilli, C., Gambini, D., Ribatti, R., Longhi, T. M., Allen, A., Corti, and M., Ponzoni, " Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy, ", Cancer Res., 63 (21), 7400-7409 (2003). cnr CNREA8 0008-5472 (Pubitemid 37413482)
20. A., Corti and M., Ponzoni, " Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs, ", Ann. N.Y. Acad. Sci., 1028, 104-112 (2004). aas ANYAA9 0077-8923 (Pubitemid 40361814)
21. Y., van Hensbergen, H. J., Broxterman, R., Hanemaaijer, A. S., Jorna, N. A., van Lent, H. M., Verheul, H. M., Pinedo, and K., Hoekman, " Soluble aminopeptidase N/CD13 in malignant and nonmalignant effusions and intratumoral fluid, ", Clin. Cancer Res., 8 (12), 3747-3754 (2002). 84q ZZZZZZ 1078-0432 (Pubitemid 35424765)
22. V., Ntziachristos, J., Ripoll, L. V., Wang, and R., Weissleder, " Looking and listening to light: the evolution of whole-body photonic imaging, ", Nat. Biotechnol., 23 (3), 313-320 (2005). nab NABIF9 1087-0156 10.1038/nbt1074 (Pubitemid 41094419)
23. Y., van Hensbergen, H. J., Broxterman, S., Rana, P. J., van Diest, M. C., Duyndam, K., Hoekman, H. M., Pinedo, and E., Boven, " Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenografts, ", Clin. Cancer Res., 10 (3), 1180-1191 (2004). 84q ZZZZZZ 1078-0432 (Pubitemid 38198920)
24. F., Curnis, G., Arrigoni, A., Sacchi, L., Fischetti, W., Arap, R., Pasqualini, and A., Corti, " Differential binding of drugs containing the, NGR, motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells, ", Cancer Res., 62 (3), 867-874 (2002). cnr CNREA8 0008-5472 (Pubitemid 34126966)
25. Y., Yokoyama and S., Ramakrishnan, " Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth, ", Cancer, 104 (2), 321-331 (2005). 3yr ZZZZZZ 0008-543X (Pubitemid 40993259)
26. A., Dirksen, S., Langereis, B. F., de Waal, M. H., van Genderen, E. W., Meijer, Q. G., de Lussanet, and T. M., Hackeng, " Design and synthesis of a bimodal target-specific contrast agent for angiogenesis, ", Org. Lett., 6 (26), 4857-4860 (2004). a8y ORLEF7 1523-7060 10.1021/ol048084u (Pubitemid 40125827)
27. K., Licha, B., Riefke, V., Ntziachristos, A., Becker, B., Chance, and W., Semmler, " Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties, and spectroscopic, in vivo, characterization, ", Photochem. Photobiol., 72 (3), 392-398 (2000). pho PHCBAP 0031-8655 10.1562/0031-8655(2000)072<0392:HCDACA>2.0.CO;2
28. D., Bordessoule, M., Jones, K. C., Gatter, and D. Y., Mason, " Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66, and CD67, ", Br. J. Haematol., 83 (3), 370-383 (1993). bjh BJHEAL 0007-1048 (Pubitemid 23080005)
29. J., Dixon, L., Kaklamanis, H., Turley, I. D., Hickson, R. D., Leek, A. L., Harris, and K. C., Gatter, " Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin, ", J. Clin. Pathol., 47 (1), 43-47 (1994). 59s JCPAAK 0021-9746 10.1136/jcp.47.1.43 (Pubitemid 24057748)
30. R., Haubner and H. J., Wester, " Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies, ", Curr. Pharm. Des., 10 (13), 1439-1455 (2004). (Pubitemid 38559759)
31. R., Haubner, H. J., Wester, F., Burkhart, R., Senekowitsch-Schmidtke, W., Weber, S. L., Goodman, H., Kessler, and M., Schwaiger, " Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics, ", J. Nucl. Med., 42 (2), 326-336 (2001). eaq JNMEAQ 0161-5505 (Pubitemid 32150525)
32. R., Haubner, H. J., Wester, U., Reuning, R., Senekowitsch-Schmidtke, B., Diefenbach, H., Kessler, G., Stocklin, and M., Schwaiger, " Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting, ", J. Nucl. Med., 40 (6), 1061-1071 (1999). eaq JNMEAQ 0161-5505 (Pubitemid 29269229)
33. X., Chen, M., Tohme, R., Park, Y., Hou, J. R., Bading, and P. S., Conti, " Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide, ", Mol. Imaging, 3 (2), 96-104 (2004). bwf MIOMBP 1535-3508 10.1162/1535350041464892
34. Z., Cheng, Y., Wu, Z., Xiong, S. S., Gambhir, and X., Chen, " Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice, ", Bioconjugate Chem., 16 (6), 1433-1441 (2005). 2t4 BCCHES 1043-1802 10.1021/bc0501698 (Pubitemid 41681509)
35. V., Ntziachristos, A. G., Yodh, M., Schnall, and B., Chance, " Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement, ", Proc. Natl. Acad. Sci. U.S.A., 97 (6), 2767-2772 (2000). pna PNASA6 0027-8424 10.1073/pnas.040570597 (Pubitemid 30159246)
36. J. M., Martinez, I., Prieto, M. J., Ramirez, C., Cueva, F., Alba, and M., Ramirez, " Aminopeptidase activities in breast cancer tissue, ", Clin. Chem., 45 (10), 1797-1802 (1999). clc CLCHAU 0009-9147 (Pubitemid 29477338)
37. M. F., Kircher, U., Mahmood, R. S., King, R., Weissleder, and L., Josephson, " A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation, ", Cancer Res., 63 (23), 8122-8125 (2003). cnr CNREA8 0008-5472 (Pubitemid 37549457)
38. A. M., De Grand and J. V., Frangioni, " An operational near-infrared fluorescence imaging system prototype for large animal surgery, ", Technol. Cancer Res. Treat., 2 (6), 553-562 (2003). bbo TCRTBS 1533-0346 (Pubitemid 38040617)